文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

将基于生理学的药代动力学模型和经典房室模型的机理推导进行合并。

Lumping of physiologically-based pharmacokinetic models and a mechanistic derivation of classical compartmental models.

机构信息

Department of Mathematics and Computer Science, Freie Universität, Berlin, Germany.

出版信息

J Pharmacokinet Pharmacodyn. 2010 Aug;37(4):365-405. doi: 10.1007/s10928-010-9165-1. Epub 2010 Jul 27.


DOI:10.1007/s10928-010-9165-1
PMID:20661651
Abstract

In drug discovery and development, classical compartment models and physiologically based pharmacokinetic (PBPK) models are successfully used to analyze and predict the pharmacokinetics of drugs. So far, however, both approaches are used exclusively or in parallel, with little to no cross-fertilization. An approach that directly links classical compartment and PBPK models is highly desirable. We derived a new mechanistic lumping approach for reducing the complexity of PBPK models and establishing a direct link to classical compartment models. The proposed method has several advantages over existing methods: Perfusion and permeability rate limited models can be lumped; the lumped model allows for predicting the original organ concentrations; and the volume of distribution at steady state is preserved by the lumping method. To inform classical compartmental model development, we introduced the concept of a minimal lumped model that allows for prediction of the venous plasma concentration with as few compartments as possible. The minimal lumped parameter values may serve as initial values for any subsequent parameter estimation process. Applying our lumping method to 25 diverse drugs, we identified characteristic features of lumped models for moderate-to-strong bases, weak bases and acids. We observed that for acids with high protein binding, the lumped model comprised only a single compartment. The proposed lumping approach established for the first time a direct derivation of simple compartment models from PBPK models and enables a mechanistic interpretation of classical compartment models.

摘要

在药物发现和开发中,经典隔室模型和基于生理学的药代动力学(PBPK)模型被成功地用于分析和预测药物的药代动力学。然而,到目前为止,这两种方法都是单独使用或并行使用的,几乎没有相互借鉴。非常需要一种直接将经典隔室模型和 PBPK 模型联系起来的方法。我们提出了一种新的机制化合并方法,用于降低 PBPK 模型的复杂性并建立与经典隔室模型的直接联系。与现有方法相比,该方法具有以下几个优点:灌注和通透性速率限制模型可以合并;合并模型允许预测原始器官浓度;并且通过合并方法保持了稳态下的分布容积。为了为经典隔室模型的开发提供信息,我们引入了最小合并模型的概念,该模型允许用尽可能少的隔室来预测静脉血浆浓度。最小合并参数值可以作为任何后续参数估计过程的初始值。我们将我们的合并方法应用于 25 种不同的药物,确定了中等至强碱、弱碱和酸的合并模型的特征。我们观察到,对于与蛋白质结合率高的酸,合并模型仅包含一个隔室。所提出的合并方法首次从 PBPK 模型直接推导出简单的隔室模型,并使经典隔室模型具有机制解释。

相似文献

[1]
Lumping of physiologically-based pharmacokinetic models and a mechanistic derivation of classical compartmental models.

J Pharmacokinet Pharmacodyn. 2010-7-27

[2]
Reduction and lumping of physiologically based pharmacokinetic models: prediction of the disposition of fentanyl and pethidine in humans by successively simplified models.

J Pharmacokinet Pharmacodyn. 2003-8

[3]
A compatibility evaluation between the physiologically based pharmacokinetic (PBPK) model and the compartmental PK model using the lumping method with real cases.

Front Pharmacol. 2022-8-12

[4]
Automated proper lumping for simplification of linear physiologically based pharmacokinetic systems.

J Pharmacokinet Pharmacodyn. 2019-8

[5]
Lumping of whole-body physiologically based pharmacokinetic models.

J Pharmacokinet Biopharm. 1998-2

[6]
Physiologically based pharmacokinetics (PBPK).

Drug Metab Rev. 2009

[7]
Determination of the Number of Tissue Groups of Kinetically Distinct Transit Time in Whole-Body Physiologically Based Pharmacokinetic (PBPK) Models I: Theoretical Consideration of Bottom-Up Approach of Lumping Tissues in Whole-Body PBPK.

AAPS J. 2022-8-24

[8]
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution.

J Pharm Sci. 2011-10

[9]
Determination of the Number of Tissue Groups of Kinetically Distinct Transit Time in Whole-Body Physiologically Based Pharmacokinetic (PBPK) Models II: Practical Application of Tissue Lumping Theories for Pharmacokinetics of Various Compounds.

AAPS J. 2022-8-24

[10]
PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach.

J Pharm Sci. 2011-10

引用本文的文献

[1]
A Continuous Intestinal Absorption Model to Predict Drug Enterohepatic Recirculation in Healthy Humans: Nalbuphine as a Model Substrate.

Mol Pharm. 2024-9-2

[2]
Parameter grouping and co-estimation in physiologically based kinetic models using genetic algorithms.

Toxicol Sci. 2024-6-26

[3]
A minimal PBPK model to accelerate preclinical development of drugs against tuberculosis.

Front Pharmacol. 2024-1-4

[4]
PBTK modeling of the pyrrolizidine alkaloid retrorsine to predict liver toxicity in mouse and rat.

Arch Toxicol. 2023-5

[5]
Investigation of simplified physiologically-based pharmacokinetic models in rat and human.

CPT Pharmacometrics Syst Pharmacol. 2023-3

[6]
Process and System Clearances in Pharmacokinetic Models: Our Basic Clearance Concepts Are Correct.

Drug Metab Dispos. 2023-4

[7]
A compatibility evaluation between the physiologically based pharmacokinetic (PBPK) model and the compartmental PK model using the lumping method with real cases.

Front Pharmacol. 2022-8-12

[8]
High-Dosage Fosfomycin Results in Adequate Plasma and Target-Site Exposure in Morbidly Obese and Nonobese Nonhyperfiltration Patients.

Antimicrob Agents Chemother. 2022-6-21

[9]
Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics.

Pharmaceutics. 2021-8-31

[10]
Meta-Assessment of Metformin Absorption and Disposition Pharmacokinetics in Nine Species.

Pharmaceuticals (Basel). 2021-6-7

本文引用的文献

[1]
Physiology-based pharmacokinetic modeling: ready to be used.

Drug Discov Today Technol. 2005

[2]
Development of a novel method for predicting human volume of distribution at steady-state of basic drugs and comparative assessment with existing methods.

J Pharm Sci. 2009-12

[3]
Modelling and PBPK simulation in drug discovery.

AAPS J. 2009-3

[4]
A population pharmacokinetic model of epidural lidocaine in geriatric patients: effects of low-dose dopamine.

Ther Drug Monit. 2008-6

[5]
Physiologically based pharmacokinetic modelling: a sub-compartmentalized model of tissue distribution.

J Pharmacokinet Pharmacodyn. 2007-12

[6]
On the volume of distribution at steady state and its relationship with two-compartmental models.

J Pharm Sci. 2008-1

[7]
Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs.

J Pharmacokinet Pharmacodyn. 2007-6

[8]
Mechanistic approaches to volume of distribution predictions: understanding the processes.

Pharm Res. 2007-5

[9]
Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery.

Chem Biodivers. 2005-11

[10]
A novel strategy for physiologically based predictions of human pharmacokinetics.

Clin Pharmacokinet. 2006

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索